727 related items for PubMed ID: 22763815
1. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[Abstract] [Full Text] [Related]
2. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[Abstract] [Full Text] [Related]
4. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
5. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
6. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
[Abstract] [Full Text] [Related]
7. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M.
Clin J Am Soc Nephrol; 2020 Feb 07; 15(2):209-218. PubMed ID: 31953303
[Abstract] [Full Text] [Related]
8. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
Hari P, Bagga A, Jindal N, Srivastava RN.
Pediatr Nephrol; 2001 Nov 07; 16(11):901-5. PubMed ID: 11685598
[Abstract] [Full Text] [Related]
9. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR, Vijaykumar M, Prahlad N, Jain DV.
Indian Pediatr; 2006 Jan 07; 43(1):39-43. PubMed ID: 16465005
[Abstract] [Full Text] [Related]
10. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP.
Nephrol Dial Transplant; 2008 Mar 07; 23(3):910-3. PubMed ID: 18039644
[Abstract] [Full Text] [Related]
11. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H, Shi X, Shen H, Li X, Wang H, Li H, Xu G, Chen J.
Clin Ther; 2012 May 07; 34(5):1112-20. PubMed ID: 22503105
[Abstract] [Full Text] [Related]
12. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
Ren H, Shen P, Li X, Pan X, Zhang W, Chen N.
Am J Nephrol; 2013 May 07; 37(1):84-90. PubMed ID: 23343906
[Abstract] [Full Text] [Related]
13. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
Ladapo TA, Esezobor CI, Lesi FE.
Pan Afr Med J; 2016 May 07; 25():258. PubMed ID: 28293374
[Abstract] [Full Text] [Related]
14. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec 07; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
15. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr 07; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
16. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 07; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
17. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.
Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, Fu H, Du L, Liu A.
Pediatr Nephrol; 2012 Nov 07; 27(11):2073-2079. PubMed ID: 22714672
[Abstract] [Full Text] [Related]
18. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical AssociationDepartment of Pediatrics, Nanjing General Hospital of Nanjing Military Command, Nanjing 21002, China. Email:njxzk@126.com..
Zhonghua Er Ke Za Zhi; 2014 Jul 07; 52(7):483-7. PubMed ID: 25224050
[Abstract] [Full Text] [Related]
19. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
Westhoff TH, Schmidt S, Zidek W, Beige J, van der Giet M.
Clin Nephrol; 2006 Jun 07; 65(6):393-400. PubMed ID: 16792133
[Abstract] [Full Text] [Related]
20. [Clinical application of tacrolimus with low-dose prednisone in 21 children with steroid-resistant nephrotic syndrome].
Yao SH, Mao JH, Xia YH, Wang DY, Chen YF, Fang CQ, Liu AM, Du LZ.
Zhonghua Er Ke Za Zhi; 2011 Nov 07; 49(11):825-8. PubMed ID: 22336304
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
